At-risk hep B crowd ignores jab; immatics touts positive midstage data on colon cancer vax;

> Investigators have concluded that more than half of adults who run a high risk of getting hepatitis B are never vaccinated against the virus. The study tracked specific groups who were more or less likely to get the jab. Report

> Canadian health officials are urging males in the country ages 9 to 26 to get vaccinated against HPV, extending a recommendation already in place for females. Story

> Germany's immatics says it gained positive midstage data for an experimental oncology vaccine targeting colorectal cancer. Release

> Investigators concluded that serious allergic reactions in children are rare after a vaccination. Story

> After fighting whooping cough outbreaks for two decades, California officials say they got through 2011 without a single death. Article

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.